Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for CVRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Research and Development Expense (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 12.36M
March 31, 2026 11.70M
December 31, 2025 11.13M
September 30, 2025 10.94M
June 30, 2025 10.30M
March 31, 2025 10.59M
December 31, 2024 11.13M
September 30, 2024 10.57M
June 30, 2024 10.76M
March 31, 2024 11.27M
December 31, 2023 11.63M
September 30, 2023 12.44M
Date Value
June 30, 2023 12.04M
March 31, 2023 11.11M
December 31, 2022 9.952M
September 30, 2022 8.703M
June 30, 2022 8.109M
March 31, 2022 8.009M
December 31, 2021 7.501M
September 30, 2021 6.214M
June 30, 2021 6.015M
March 31, 2021 5.891M
December 31, 2020 6.41M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
NeuroPace, Inc. 27.69M
Accuray, Inc. 37.80M
Micron Solutions, Inc. --
Orthofix Medical, Inc. 60.33M
ResMed, Inc. 378.28M